Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions
Matthias Alexa, Annette Hasenburg, Marco Johannes Battista
Cancers (2021) Vol. 13, Iss. 6, pp. 1478-1478
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 464
Molecular Basis of Endometriosis and Endometrial Cancer: Current Knowledge and Future Perspectives
Milan Terzić, Gulzhanat Aimagambetova, Jeannette Kunz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9274-9274
Open Access | Times Cited: 68
Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions
Nayanar-Adela Contreras, Jordi Sabadell, Paula Verdaguer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2531-2531
Open Access | Times Cited: 51
Current Approaches to the Management of Patients with Endometrial Cancer
Emmanouil Kalampokas, Georgios Giannis, Theodoros Kalampokas, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4500-4500
Open Access | Times Cited: 44
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 22, pp. 4564-4574
Open Access | Times Cited: 35
HER2 Amplification in p53-Mutated Endometrial Carcinomas
Ambre Balestra, Denis Larsimont, Jean‐Christophe Noël
Cancers (2023) Vol. 15, Iss. 5, pp. 1435-1435
Open Access | Times Cited: 25
An Overview of Endometrial Cancer with Novel Therapeutic Strategies
Theresa Kuhn, Saeeda Dhanani, Sarfraz Ahmad
Current Oncology (2023) Vol. 30, Iss. 9, pp. 7904-7919
Open Access | Times Cited: 25
The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?
Kyung Hee Han, Noh-Hyun Park, Maria Lee, et al.
Journal of Gynecologic Oncology (2024) Vol. 35, Iss. 5
Open Access | Times Cited: 14
Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Olincă, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1385-1385
Open Access | Times Cited: 1
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification
Amy Jamieson, Jutta Huvila, Emily F. Thompson, et al.
Gynecologic Oncology (2022) Vol. 165, Iss. 2, pp. 201-214
Closed Access | Times Cited: 32
Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
Seon‐Mi Lee, Sanghoon Lee, Hyun‐Woong Cho, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 974-974
Open Access | Times Cited: 17
MRI- and Histologic-Molecular-Based Radio-Genomics Nomogram for Preoperative Assessment of Risk Classes in Endometrial Cancer
Veronica Celli, Michele Guerreri, Angelina Pernazza, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5881-5881
Open Access | Times Cited: 25
Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer—Driving New Tools for Endometrial Preservation?
Miriam Dellino, Marco Cerbone, Antonio Simone Laganà, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9780-9780
Open Access | Times Cited: 16
The Possible Role of Mycotoxins in the Pathogenesis of Endometrial Cancer
Márkó Unicsovics, Zsófia Molnár, Miklós Mézes, et al.
Toxins (2024) Vol. 16, Iss. 6, pp. 236-236
Open Access | Times Cited: 6
Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols
Zihui Yang, Xi Yang, Xinyu Liu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Fertility Preservation in Endometrial Cancer—Treatment and Molecular Aspects
Melanie Schubert, Liselotte Mettler, Aarti Deenadayal Tolani, et al.
Medicina (2023) Vol. 59, Iss. 2, pp. 221-221
Open Access | Times Cited: 12
Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance
Mohd Nazzary Mamat Yusof, Kah Teik Chew, Nirmala Chandralega Kampan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15233-15233
Open Access | Times Cited: 12
Pembrolizumab plus lenvatinib as first-line therapy for patients with mismatch repair-proficient advanced endometrial cancer: A United States-based cost-effectiveness analysis
Kun Liu, Youwen Zhu, Yangying Zhou, et al.
Gynecologic Oncology (2022) Vol. 166, Iss. 3, pp. 582-588
Closed Access | Times Cited: 19
The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis
Alaa Salah Jumaah, Hawraa Sahib Al‐Haddad, Katherine McAllister, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263585-e0263585
Open Access | Times Cited: 17
Clinical analysis of molecular typing of 146 cases of endometrial carcinoma
Bo Zhang, Dan Zhou, Shuo Zhang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Clinicopathological and prognostic significance of the microcystic elongated and fragmented pattern in endometrial cancer: a systematic review and meta-analysis
Peng Jia, Baofeng Duan, Yan Zhang
BMJ Open (2025) Vol. 15, Iss. 1, pp. e092006-e092006
Open Access
Preclinical research models for endometrial cancer: development and selection of animal models
Xue Yang, Wei Shi, Bing Lun, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Uterine Carcinosarcoma—A Retrospective Cohort Analysis from a Tertiary Centre on Epidemiology, Management Approach, Outcomes and Survival Patterns
Sarah Louise Smyth, Katherine Ripullone, Andreas Zouridis, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 635-635
Open Access
Association of oral contraceptives and risk of endometrial cancer: A systematic review and meta‐analysis
András Harajka, Tímea Hercsik, Isabel Pinto Amorim das Virgens, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2025)
Open Access
Molecular Classification of Endometrial Carcinoma: Insights From a Teaching Hospital
Samah Saharti, Fadwa J. Altaf
International Journal of Gynecological Pathology (2025)
Closed Access
Page 1 - Next Page

Scroll to top